Changing TRT services: transfer the clinical story, not only the latest result

Start with the original assessment, not just the current hormone number

Request the clinical account of the symptoms and findings that led to the initial treatment decision, including the relevant laboratory reports and explanation of the diagnosis. The Endocrine Society’s July 2026 statement emphasizes symptoms, consistent accurate measurements and assessment of contributors. A receiving clinician may need that history to understand what was established before treatment.

Reports obtained before and during therapy answer different questions and should remain identifiable as such. Do not try to recreate missing baseline information by changing treatment yourself. Explain what records exist and let the receiving clinician decide how to assess the situation. Missing documentation is a reason for clarification, not an invitation to invent an earlier diagnosis or result.

Describe the original treatment goal in ordinary language as well as preserving records. That helps the next clinician ask whether the same concern still matters.

Collect the prescription history as well as the medicine list

Include the actual medicine labels and information about the prescriber and dispensing pharmacy. Identify previous changes and the documented reasons when available. A list that says testosterone alone may omit the formulation, concentration or route needed to understand the previous care. Other prescription and nonprescription products also belong in the clinical history.

The pharmacy-record guide explains those distinctions. A label from the specific Depo-Testosterone product cannot establish the contents of an unidentified compounded preparation. The receiving clinician and pharmacist should resolve the actual product identity, especially when records use similar names without clearly identifying the formulation.

Transfer follow-up findings, including unresolved concerns

Bring the reports and clinical notes used to review benefit, adverse effects and safety during treatment. The Endocrine guideline calls for evaluation after initiation; knowing only that tests were performed does not show what the treating clinician concluded. Include ongoing symptoms and questions still awaiting an answer, not just results that appear reassuring.

Blood-pressure information and relevant blood-count or prostate-related assessment may be part of that history, depending on the clinical plan. Ask who currently holds each record and which team will respond to a result that arrives during the transition. The laboratory handoff guide distinguishes report delivery from interpretation. Avoid assuming that both practices are reviewing the same information.

Request copies through the organization that holds them

HHS explains that patients generally have a right, with exceptions, to inspect and receive copies of medical and billing records held by providers and plans covered by the Privacy Rule. That scope matters: the rule should not be described as an identical promise from every wellness app or retail website. Ask the relevant practice or laboratory about its records-request process.

A portal may provide some documents without containing the full assessment or all outside reports. Specify what is needed and ask how it can be sent in a usable form. HHS also distinguishes access from automatic provider-to-provider sharing. Do not assume a new clinic can retrieve everything merely because both organizations use online systems or the same account email address.

Check that the receiving team has the material and the task

Confirm where records should be sent, whether they arrived and who will review them. An upload confirmation proves a file was submitted, not that a clinical decision has been made. If a report is incomplete or difficult to read, ask the sender for a complete copy rather than manually reconstruct values or omit the reference information.

MedlinePlus explains that results need clinical context and may involve different methods and reference ranges. Keep the original reports available. Ask the receiving clinician what additional assessment, if any, is needed and how current concerns will be addressed. Accepting outside records does not necessarily mean accepting every earlier conclusion or agreeing to continue an existing prescription unchanged.

Make responsibility during the transition explicit

Ask the existing and receiving teams how unresolved clinical questions will be handled while records are being reviewed. Which clinician should receive a new concern? Who will interpret a result that arrives during the transition? A new account and a record-transfer acknowledgment do not necessarily answer those questions. The Endocrine guideline treats follow-up as an evaluation of response and adverse effects, not simply the presence of a document.

Our administrative-record guide explains why an account event and a clinical decision need separate interpretation. The FTC’s general guidance supports preserving cancellation records if a billing arrangement ends. An administrative cancellation does not supply medical instructions. Raise unresolved care questions with the responsible clinicians rather than infer a treatment change from an account notification.

Make the handoff a documented conversation

Before considering the transfer complete, seek a clear explanation of which clinician is now responsible for treatment decisions, who reviews future tests and how questions reach that team. Include changed fertility goals, new diagnoses or other care that the original practice may not know about. The goal is a shared understanding of current care, not merely an archive of old files.

Our CoreAge service review and comparison examine public arrangements without guaranteeing acceptance of a transferring patient. This guide was prepared for the CoreAge Rx publishing network; the affiliation is relevant to readers evaluating its perspective. It neither endorses treatment nor establishes that a receiving practice will accept a patient. A useful transfer preserves the clinical reasoning and unresolved issues, while leaving the receiving professional responsible for explaining the actual next plan.

Make the unfinished responsibility part of the handoff

A transferred file can contain recent information while leaving its interpretation unfinished. The Emory review separates published testing during treatment from evidence that a particular result was explained. The Mount Sinai review connects cause evaluation and progress review with the limits of a public collaboration statement.

The UCLA review considers connected care and monitoring, while the UCI review asks whether a described specialty relationship became an actual clinical exchange. These are reasons to carry forward pending questions as well as completed findings. A new clinician needs to know which conclusion has been reached and which task remains open. The existence of cooperating services does not prove that anyone has accepted that unfinished task.